全球呼吸道感染疾病診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

全球呼吸道感染疾病診斷市場預計將從2025年的147.1億美元成長至2034年的192.3億美元，2026年至2034年的複合年成長率（CAGR）為3.02%。受各治療領域對藥物的強勁需求驅動，全球合成小分子原料藥（API）市場也呈現穩定成長態勢。小分子原料藥在治療心血管疾病、腫瘤、神經系統疾病和糖尿病等慢性疾病方面仍然至關重要。學名藥生產的擴張進一步推動了原料藥藥的生產。更多地將生產外包給契約製造組織（CMO）有助於製藥公司最佳化成本並提高效率。全球醫療保健支出的成長也支撐了市場的持續擴張。

化學合成技術和製程最佳化的進步正在提升產品品質和規模化生產能力。製造商致力於遵守嚴格的監管標準，以確保產品的安全性和有效性。小分子候選藥物研發管線的不斷擴展持續為原料藥供應商創造商機。新興市場正大力投資醫藥基礎設施，以增強國內生產能力。此外，癌症治療的不斷發展也推動了對高活性原料藥的需求。

未來，永續且環保的化學實踐可望減少對環境的影響，進而對市場產生積極作用。製藥公司與原料藥生產商之間的策略合作將增強供應鏈的韌性。連續生產流程等技術創新正在提高營運效率。開發中國家醫療保健覆蓋率的擴大將開闢新的成長途徑。總而言之，持續的創新和不斷成長的藥品需求將確保市場穩步發展。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球呼吸道感染疾病診斷市場：依產品分類

• 市場分析、洞察與預測
• 設備（影像檢查、呼吸檢測設備及其他設備）
• 消耗品
• 服務

第5章 全球呼吸道感染疾病診斷市場：依樣本數分類

• 市場分析、洞察與預測
• 唾液
• 鼻咽拭子（NPS）
• 前鼻腔
• 血
• 其他

第6章 全球呼吸道感染疾病診斷市場：依應用分類

• 市場分析、洞察與預測
• COVID-19
• 流感
• 呼吸道融合細胞病毒（RSV）
• 結核
• 鏈球菌檢測
• 其他呼吸系統疾病檢查

第7章 全球呼吸道感染疾病診斷市場：依技術分類

• 市場分析、洞察與預測
• 免疫檢測
• 分子診斷
• 微生物學
• 其他技術

第8章 全球呼吸道感染疾病診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診斷檢查室
• 診所
• 其他

第9章 全球呼吸道感染疾病診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Becton Dickinson And Company（BD）
  • BioMerieux SA
  • Bio-Rad LaboratoriesInc
  • Bruker Corporation（ELITechGroup/Hain Lifescience GmbH）
  • Certest Biotec SL
  • Danaher Corporation（Cepheid）
  • DiaSorin SpA（Luminex Corporation）
  • F. Hoffmann-La Roche Ltd.（Roche Diagnostics/GenMark Diagnostics）
  • HologicInc
  • QIAGEN NV
  • QuidelOrtho Corporation
  • SD Biosensor, Inc.（Meridian Bioscience, Inc.）
  • Seegene Inc
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc

The global infectious respiratory disease diagnostics market size is expected to reach USD 19.23 Billion in 2034 from USD 14.71 Billion in 2025, growing at a CAGR of 3.02 during 2026-2034.The Global Synthetic Small Molecule API Market is experiencing steady growth driven by the strong demand for pharmaceutical drugs across therapeutic areas. Small molecule active pharmaceutical ingredients remain essential for treating chronic conditions such as cardiovascular diseases, oncology, neurological disorders, and diabetes. The expansion of generic drug production is further stimulating API manufacturing. Increasing outsourcing to contract manufacturing organizations helps pharmaceutical companies optimize costs and improve efficiency. Rising global healthcare expenditure is also supporting continuous market expansion.

Advancements in chemical synthesis technologies and process optimization are improving product quality and scalability. Manufacturers are focusing on compliance with stringent regulatory standards to ensure safety and efficacy. The growing pipeline of small molecule drug candidates continues to create opportunities for API suppliers. Emerging economies are investing heavily in pharmaceutical infrastructure to strengthen domestic production capabilities. Additionally, demand for high-potency APIs is rising due to increasing oncology drug development.

In the future, the market is expected to benefit from sustainable and green chemistry initiatives that reduce environmental impact. Strategic collaborations between pharmaceutical companies and API producers will enhance supply chain resilience. Technological innovations such as continuous manufacturing processes are improving operational efficiency. Expanding healthcare access in developing countries will create new growth avenues. Overall, consistent innovation and increasing drug demand will ensure steady market progression.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
• Consumables
• Services

By Sample

• Saliva
• Nasopharyngeal Swabs (NPS)
• Anterior Nasal Region
• Blood
• Others

By Application

• COVID-19
• Influenza
• Respiratory Syncytial Virus (RSV)
• Tuberculosis
• Streptococcus Testing
• Other Respiratory Disease Testing

By Technology

• Immunoassay
• Molecular Diagnostics
• Microbiology
• Other Technologies

By End Use

• Hospitals
• Diagnostic Laboratories
• Physician Offices
• Others

COMPANIES PROFILED

• Abbott Laboratories, Becton Dickinson and Company (BD), bioMerieux SA, Bio-Rad Laboratories, Inc., Bruker Corporation (ELITechGroup / Hain Lifescience GmbH), Certest Biotec S.L., Danaher Corporation (Cepheid), DiaSorin S.p.A. (Luminex Corporation), F. Hoffmann-La Roche Ltd, ., (Roche Diagnostics / GenMark Diagnostics), Hologic, Inc., QIAGEN N.V., QuidelOrtho Corporation, SD Biosensor, Inc. (Meridian Bioscience, Inc.), Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample
• 5.2. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Nasopharyngeal Swabs (NPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Anterior Nasal Region Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. COVID-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Respiratory Syncytial Virus (RSV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Tuberculosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Streptococcus Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Respiratory Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Technology
• 7.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Physician Offices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Sample
  • 9.2.3 By Application
  • 9.2.4 By Technology
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Sample
  • 9.3.3 By Application
  • 9.3.4 By Technology
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Sample
  • 9.4.3 By Application
  • 9.4.4 By Technology
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Sample
  • 9.5.3 By Application
  • 9.5.4 By Technology
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Sample
  • 9.6.3 By Application
  • 9.6.4 By Technology
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 Becton Dickinson And Company (BD)
  • 11.2.3 BioMerieux SA
  • 11.2.4 Bio-Rad LaboratoriesInc
  • 11.2.5 Bruker Corporation (ELITechGroup / Hain Lifescience GmbH)
  • 11.2.6 Certest Biotec S.L
  • 11.2.7 Danaher Corporation (Cepheid)
  • 11.2.8 DiaSorin S.p.A. (Luminex Corporation)
  • 11.2.9 F. Hoffmann-La Roche Ltd. (Roche Diagnostics / GenMark Diagnostics)
  • 11.2.10 HologicInc
  • 11.2.11 QIAGEN N.V
  • 11.2.12 QuidelOrtho Corporation
  • 11.2.13 SD Biosensor, Inc. (Meridian Bioscience, Inc.)
  • 11.2.14 Seegene Inc
  • 11.2.15 Siemens Healthineers AG
  • 11.2.16 Thermo Fisher Scientific Inc